Protein | Taxonomy | lestaurtinib (IC50) | staurosporine (IC50) |
Chain A, Glycogen Synthase Kinase-3 Beta | Homo sapiens (human) | | 0.015 |
Chain B, Glycogen Synthase Kinase-3 Beta | Homo sapiens (human) | | 0.015 |
Chain A, Glycogen Synthase Kinase-3 Beta | Homo sapiens (human) | | 0.015 |
Chain A, Tyrosine-protein kinase ZAP-70 | Homo sapiens (human) | | 0.0558 |
Chain A, Tyrosine-protein kinase SYK | Homo sapiens (human) | | 0.012 |
Chain A, Proto-oncogene serine/threonine-protein kinase Pim-1 | Homo sapiens (human) | | 0.01 |
Chain A, Proto-oncogene serine/threonine-protein kinase Pim-1 | Homo sapiens (human) | | 0.01 |
Chain X, Proto-oncogene tyrosine-protein kinase Fyn | Homo sapiens (human) | | 0.0048 |
Chain A, Serine/threonine-protein kinase TAO2 | Rattus norvegicus (Norway rat) | | 3 |
epidermal growth factor receptor isoform a precursor | Homo sapiens (human) | | 0.4467 |
Serine/threonine-protein kinase Sgk1 | Homo sapiens (human) | | 0.01 |
Cell division cycle 7-related protein kinase | Homo sapiens (human) | | 0.0549 |
Serine/threonine-protein kinase PLK4 | Homo sapiens (human) | | 0.0083 |
Serine/threonine-protein kinase 25 | Homo sapiens (human) | | 0.0029 |
Citron Rho-interacting kinase | Homo sapiens (human) | | 0.749 |
Dual specificity mitogen-activated protein kinase kinase 7 | Homo sapiens (human) | | 0.9255 |
Telomerase reverse transcriptase | Homo sapiens (human) | | 6.9517 |
Serine/threonine-protein kinase Chk1 | Homo sapiens (human) | | 0.1772 |
Inhibitor of nuclear factor kappa-B kinase subunit beta | Homo sapiens (human) | | 0.5561 |
Aurora kinase A | Homo sapiens (human) | | 0.0087 |
Cyclin-G-associated kinase | Homo sapiens (human) | | 0.011 |
Serine/threonine-protein kinase DCLK1 | Homo sapiens (human) | | 0.267 |
Inhibitor of nuclear factor kappa-B kinase subunit alpha | Homo sapiens (human) | | 0.1265 |
Muscle, skeletal receptor tyrosine-protein kinase | Homo sapiens (human) | | 0.1161 |
Mitogen-activated protein kinase 13 | Homo sapiens (human) | | 0.4137 |
3-phosphoinositide-dependent protein kinase 1 | Homo sapiens (human) | | 0.0072 |
Death-associated protein kinase 3 | Homo sapiens (human) | | 0.0026 |
Mitogen-activated protein kinase kinase kinase 7 | Homo sapiens (human) | | 0.0565 |
Receptor-interacting serine/threonine-protein kinase 2 | Homo sapiens (human) | | 0.356 |
Dual specificity tyrosine-phosphorylation-regulated kinase 3 | Homo sapiens (human) | | 0.0231 |
NUAK family SNF1-like kinase 1 | Homo sapiens (human) | | 0.003 |
Cyclin-T1 | Homo sapiens (human) | | 0.0118 |
Cyclin-T2 | Homo sapiens (human) | | 0.0038 |
Tyrosine-protein kinase JAK2 | Homo sapiens (human) | | 0.0016 |
Rho-associated protein kinase 2 | Homo sapiens (human) | | 0.0045 |
Serine/threonine-protein kinase ULK1 | Homo sapiens (human) | | 0.0096 |
Serine/threonine-protein kinase/endoribonuclease IRE1 | Homo sapiens (human) | | 0.1246 |
Ribosomal protein S6 kinase alpha-5 | Homo sapiens (human) | | 0.0011 |
Ribosomal protein S6 kinase alpha-4 | Homo sapiens (human) | | 0.0071 |
Serine/threonine-protein kinase 16 | Homo sapiens (human) | | 0.2385 |
Cyclin-K | Homo sapiens (human) | | 0.0948 |
Serine/threonine-protein kinase PAK 3 | Homo sapiens (human) | | 0.0003 |
Serine/threonine-protein kinase 17B | Homo sapiens (human) | | 0.0258 |
Serine/threonine-protein kinase 10 | Homo sapiens (human) | | 0.008 |
Serine/threonine-protein kinase D3 | Homo sapiens (human) | | 0.1446 |
Cyclin-dependent kinase 14 | Homo sapiens (human) | | 0.1145 |
G2/mitotic-specific cyclin-B2 | Homo sapiens (human) | | 0.0107 |
Mitogen-activated protein kinase kinase kinase 6 | Homo sapiens (human) | | 0.2829 |
Mitogen-activated protein kinase kinase kinase kinase 4 | Homo sapiens (human) | | 0.0005 |
Serine/threonine-protein kinase LATS1 | Homo sapiens (human) | | 0.013 |
Serine/threonine-protein kinase PAK 4 | Homo sapiens (human) | | 0.0132 |
Serine/threonine-protein kinase Chk2 | Homo sapiens (human) | | 0.0212 |
G1/S-specific cyclin-E2 | Homo sapiens (human) | | 0.011 |
cAMP-dependent protein kinase catalytic subunit alpha | Bos taurus (cattle) | | 0.0812 |
Tyrosine-protein kinase ABL1 | Homo sapiens (human) | | 0.1233 |
Proto-oncogene tyrosine-protein kinase Src | Gallus gallus (chicken) | | 0.0063 |
Epidermal growth factor receptor | Homo sapiens (human) | | 0.083 |
RAF proto-oncogene serine/threonine-protein kinase | Homo sapiens (human) | | 0.1281 |
Receptor tyrosine-protein kinase erbB-2 | Homo sapiens (human) | | 0.0713 |
High affinity nerve growth factor receptor | Homo sapiens (human) | | 0.2403 |
Protein kinase C gamma type | Homo sapiens (human) | | 0.1167 |
Platelet-derived growth factor receptor beta | Mus musculus (house mouse) | | 0.002 |
Protein kinase C alpha type | Rattus norvegicus (Norway rat) | | 0.2327 |
Protein kinase C beta type | Homo sapiens (human) | | 0.0684 |
Prostaglandin G/H synthase 1 | Ovis aries (sheep) | | 0.056 |
Insulin receptor | Homo sapiens (human) | | 0.0706 |
Tyrosine-protein kinase Lck | Homo sapiens (human) | | 0.1784 |
Tyrosine-protein kinase Fyn | Homo sapiens (human) | | 0.0929 |
Retinoblastoma-associated protein | Homo sapiens (human) | | 0.066 |
Cyclin-dependent kinase 1 | Homo sapiens (human) | | 0.0075 |
Tyrosine-protein kinase Fes/Fps | Homo sapiens (human) | | 0.0039 |
Macrophage colony-stimulating factor 1 receptor | Homo sapiens (human) | | 0.1269 |
Tyrosine-protein kinase Yes | Homo sapiens (human) | | 0.0029 |
Tyrosine-protein kinase Lyn | Homo sapiens (human) | | 0.0012 |
Proto-oncogene tyrosine-protein kinase receptor Ret | Homo sapiens (human) | | 0.0021 |
Insulin-like growth factor 1 receptor | Homo sapiens (human) | | 0.5534 |
Hepatocyte growth factor receptor | Homo sapiens (human) | | 0.1917 |
Tyrosine-protein kinase HCK | Homo sapiens (human) | | 0.0025 |
Proto-oncogene tyrosine-protein kinase ROS | Homo sapiens (human) | | 0.0004 |
Protein kinase C delta type | Rattus norvegicus (Norway rat) | | 0.274 |
Protein kinase C epsilon type | Rattus norvegicus (Norway rat) | | 0.274 |
Protein kinase C zeta type | Rattus norvegicus (Norway rat) | | 0.274 |
Platelet-derived growth factor receptor beta | Homo sapiens (human) | | 0.3707 |
Tyrosine-protein kinase Fgr | Homo sapiens (human) | | 0.0009 |
Cytochrome P450 2D6 | Homo sapiens (human) | | 0.0002 |
Mast/stem cell growth factor receptor Kit | Homo sapiens (human) | | 0.0412 |
Breakpoint cluster region protein | Homo sapiens (human) | | 0.0945 |
Calcium/calmodulin-dependent protein kinase type II subunit alpha | Rattus norvegicus (Norway rat) | | 0.059 |
Serine/threonine-protein kinase pim-1 | Homo sapiens (human) | | 0.0216 |
Fibroblast growth factor receptor 1 | Homo sapiens (human) | | 0.0699 |
Cyclin-dependent kinase 1 | Mus musculus (house mouse) | | 0.008 |
Cyclin-dependent kinase 4 | Homo sapiens (human) | | 0.0429 |
Proto-oncogene tyrosine-protein kinase Src | Homo sapiens (human) | | 0.3642 |
Acyl-CoA desaturase 1 | Mus musculus (house mouse) | | 3.4 |
Insulin receptor-related protein | Homo sapiens (human) | | 0.0113 |
G2/mitotic-specific cyclin-B1 | Homo sapiens (human) | | 0.0088 |
Dipeptidyl peptidase 4 | Rattus norvegicus (Norway rat) | | 0.003 |
5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | | 4 |
Serine/threonine-protein kinase B-raf | Homo sapiens (human) | | 0.0107 |
Insulin receptor | Mus musculus (house mouse) | | 0.2 |
Phosphorylase b kinase gamma catalytic chain, liver/testis isoform | Homo sapiens (human) | | 0.0004 |
Platelet-derived growth factor receptor alpha | Homo sapiens (human) | | 0.0007 |
Tyrosine-protein kinase Fer | Homo sapiens (human) | | 0.0008 |
Protein kinase C alpha type | Homo sapiens (human) | | 0.0655 |
cAMP-dependent protein kinase catalytic subunit alpha | Homo sapiens (human) | | 0.0115 |
Vascular endothelial growth factor receptor 1 | Homo sapiens (human) | | 0.0149 |
Cytochrome P450 11B2, mitochondrial | Homo sapiens (human) | | 0.011 |
Interferon-induced, double-stranded RNA-activated protein kinase | Homo sapiens (human) | | 0.1 |
Amine oxidase [flavin-containing] B | Rattus norvegicus (Norway rat) | | 0.0025 |
Casein kinase II subunit alpha' | Homo sapiens (human) | | 2.0215 |
Cyclin-A2 | Homo sapiens (human) | | 0.009 |
Cannabinoid receptor 1 | Rattus norvegicus (Norway rat) | | 0.01 |
Serine/threonine-protein kinase MAK | Homo sapiens (human) | | 0.0257 |
Ephrin type-A receptor 1 | Homo sapiens (human) | | 0.0947 |
Fibroblast growth factor receptor 2 | Homo sapiens (human) | | 0.0504 |
Receptor tyrosine-protein kinase erbB-3 | Homo sapiens (human) | | 0.0106 |
Fibroblast growth factor receptor 4 | Homo sapiens (human) | | 0.17 |
Fibroblast growth factor receptor 3 | Homo sapiens (human) | | 0.0554 |
cAMP-dependent protein kinase catalytic subunit gamma | Homo sapiens (human) | | 0.0137 |
Cyclin-O | Homo sapiens (human) | | 0.0015 |
cAMP-dependent protein kinase catalytic subunit beta | Homo sapiens (human) | | 0.0148 |
Ribosomal protein S6 kinase beta-1 | Homo sapiens (human) | | 0.0007 |
Tyrosine-protein kinase JAK1 | Homo sapiens (human) | | 0.004 |
Sodium-dependent dopamine transporter | Rattus norvegicus (Norway rat) | | 0.028 |
G1/S-specific cyclin-D1 | Homo sapiens (human) | | 0.0355 |
Protein kinase C eta type | Homo sapiens (human) | | 0.1165 |
Cyclin-C | Homo sapiens (human) | | 0.0105 |
G1/S-specific cyclin-E1 | Homo sapiens (human) | | 0.0108 |
Cyclin-dependent kinase 2 | Homo sapiens (human) | | 0.0073 |
Beta-adrenergic receptor kinase 1 | Homo sapiens (human) | | 1.1595 |
Platelet-derived growth factor receptor alpha | Mus musculus (house mouse) | | 0.002 |
Mitogen-activated protein kinase 3 | Homo sapiens (human) | | 4.6724 |
MAP/microtubule affinity-regulating kinase 3 | Homo sapiens (human) | | 0.0004 |
cAMP-dependent protein kinase catalytic subunit alpha | Rattus norvegicus (Norway rat) | | 0.055 |
Mitogen-activated protein kinase 1 | Homo sapiens (human) | | 2.6853 |
Ephrin type-A receptor 2 | Homo sapiens (human) | | 0.1257 |
Ephrin type-A receptor 3 | Homo sapiens (human) | | 0.0347 |
Ephrin type-A receptor 8 | Homo sapiens (human) | | 0.1061 |
Ephrin type-B receptor 2 | Homo sapiens (human) | | 0.1191 |
Leukocyte tyrosine kinase receptor | Homo sapiens (human) | | 0.0173 |
Non-receptor tyrosine-protein kinase TYK2 | Homo sapiens (human) | | 0.0137 |
G1/S-specific cyclin-D3 | Homo sapiens (human) | | 0.055 |
Tyrosine-protein kinase receptor UFO | Homo sapiens (human) | | 0.0131 |
RAC-alpha serine/threonine-protein kinase | Homo sapiens (human) | | 0.1848 |
RAC-beta serine/threonine-protein kinase | Homo sapiens (human) | | 0.4119 |
G protein-coupled receptor kinase 4 | Homo sapiens (human) | | 0.0914 |
Kinesin-1 heavy chain | Homo sapiens (human) | | 0.0015 |
G protein-coupled receptor kinase 5 | Homo sapiens (human) | | 0.0489 |
Hexokinase-4 | Homo sapiens (human) | | 0.0006 |
Beta-adrenergic receptor kinase 2 | Homo sapiens (human) | | 0.856 |
Vascular endothelial growth factor receptor 3 | Homo sapiens (human) | | 0.0146 |
Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | | 0.1791 |
Dual specificity mitogen-activated protein kinase kinase 2 | Homo sapiens (human) | | 0.026 |
Receptor-type tyrosine-protein kinase FLT3 | Homo sapiens (human) | | 0.0014 |
Bone morphogenetic protein receptor type-1A | Homo sapiens (human) | | 4.288 |
Activin receptor type-1B | Homo sapiens (human) | | 9.118 |
TGF-beta receptor type-1 | Homo sapiens (human) | | 2.2823 |
Serine/threonine-protein kinase receptor R3 | Homo sapiens (human) | | 0.85 |
Tyrosine-protein kinase CSK | Homo sapiens (human) | | 0.2071 |
Protein kinase C iota type | Homo sapiens (human) | | 0.1739 |
Megakaryocyte-associated tyrosine-protein kinase | Homo sapiens (human) | | 0.442 |
Tyrosine-protein kinase Tec | Homo sapiens (human) | | 0.0338 |
Tyrosine-protein kinase TXK | Homo sapiens (human) | | 0.0203 |
Tyrosine-protein kinase ABL2 | Homo sapiens (human) | | 0.0505 |
Tyrosine-protein kinase FRK | Homo sapiens (human) | | 0.0108 |
G protein-coupled receptor kinase 6 | Homo sapiens (human) | | 0.0473 |
Tyrosine-protein kinase ZAP-70 | Homo sapiens (human) | | 0.0175 |
Tyrosine-protein kinase SYK | Homo sapiens (human) | | 0.0057 |
Mitogen-activated protein kinase 8 | Homo sapiens (human) | | 1.1067 |
Mitogen-activated protein kinase 9 | Homo sapiens (human) | | 2.0555 |
Dual specificity mitogen-activated protein kinase kinase 4 | Homo sapiens (human) | | 0.863 |
Phosphorylase b kinase regulatory subunit alpha, liver isoform | Homo sapiens (human) | | 0.0005 |
Phosphorylase b kinase regulatory subunit alpha, skeletal muscle isoform | Homo sapiens (human) | | 0.0005 |
Dual specificity mitogen-activated protein kinase kinase 3 | Homo sapiens (human) | | 0.0099 |
Casein kinase I isoform alpha | Homo sapiens (human) | | 3.412 |
Casein kinase I isoform delta | Homo sapiens (human) | | 1.4 |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | Homo sapiens (human) | | 9 |
MAP kinase-activated protein kinase 2 | Homo sapiens (human) | | 0.735 |
Cyclin-dependent kinase 8 | Homo sapiens (human) | | 0.0105 |
Casein kinase I isoform epsilon | Homo sapiens (human) | | 1.4 |
Dual specificity protein kinase CLK1 | Homo sapiens (human) | | 0.0108 |
Dual specificity protein kinase CLK2 | Homo sapiens (human) | | 0.6508 |
Dual specificity protein kinase CLK3 | Homo sapiens (human) | | 0.92 |
Glycogen synthase kinase-3 alpha | Homo sapiens (human) | | 0.0103 |
Glycogen synthase kinase-3 beta | Homo sapiens (human) | | 0.0435 |
D(1A) dopamine receptor | Sus scrofa (pig) | | 0.001 |
Cyclin-dependent kinase 7 | Homo sapiens (human) | | 0.2793 |
Cyclin-dependent kinase 9 | Homo sapiens (human) | | 0.0474 |
Tyrosine-protein kinase Blk | Homo sapiens (human) | | 0.0011 |
Interleukin-1 receptor-associated kinase 1 | Homo sapiens (human) | | 0.0377 |
Ribosomal protein S6 kinase alpha-3 | Homo sapiens (human) | | 0.0002 |
Cytoplasmic tyrosine-protein kinase BMX | Homo sapiens (human) | | 0.0046 |
cAMP-dependent protein kinase catalytic subunit PRKX | Homo sapiens (human) | | 0.0014 |
Cyclin-H | Homo sapiens (human) | | 0.2793 |
CDK-activating kinase assembly factor MAT1 | Homo sapiens (human) | | 0.1216 |
Serine/threonine-protein kinase Nek2 | Homo sapiens (human) | | 1.7683 |
Serine/threonine-protein kinase Nek4 | Homo sapiens (human) | | 0.0851 |
Tyrosine-protein kinase JAK3 | Homo sapiens (human) | | 0.0084 |
Dual specificity mitogen-activated protein kinase kinase 6 | Homo sapiens (human) | | 0.0036 |
Serine/threonine-protein kinase PLK1 | Homo sapiens (human) | | 0.4397 |
Death-associated protein kinase 1 | Homo sapiens (human) | | 0.0101 |
LIM domain kinase 1 | Homo sapiens (human) | | 0.0026 |
LIM domain kinase 2 | Homo sapiens (human) | | 0.0956 |
Mitogen-activated protein kinase 12 | Homo sapiens (human) | | 0.4512 |
Mitogen-activated protein kinase 10 | Homo sapiens (human) | | 0.0731 |
5'-AMP-activated protein kinase subunit gamma-1 | Homo sapiens (human) | | 1.1354 |
Ephrin type-B receptor 3 | Homo sapiens (human) | | 1.2855 |
Ephrin type-A receptor 5 | Homo sapiens (human) | | 0.0159 |
Ephrin type-B receptor 4 | Homo sapiens (human) | | 0.1869 |
Ephrin type-B receptor 1 | Homo sapiens (human) | | 0.0694 |
Ephrin type-A receptor 4 | Homo sapiens (human) | | 0.0105 |
Serine/threonine-protein kinase SIK1 | Homo sapiens (human) | | 0.0009 |
Calcium-dependent protein kinase 1 | Plasmodium falciparum K1 | | 0.24 |
Protein kinase C gamma type | Rattus norvegicus (Norway rat) | | 0.2168 |
Casein kinase II subunit beta | Homo sapiens (human) | | 3.4 |
Casein kinase II subunit alpha | Homo sapiens (human) | | 3.4723 |
Protein kinase C beta type | Rattus norvegicus (Norway rat) | | 0.2029 |
SRSF protein kinase 2 | Homo sapiens (human) | | 0.206 |
Casein kinase I isoform gamma-2 | Homo sapiens (human) | | 1.9467 |
Cyclin-A1 | Homo sapiens (human) | | 0.0013 |
Mitogen-activated protein kinase kinase kinase 9 | Homo sapiens (human) | | 0.0044 |
MO15-related protein kinase Pfmrk | Plasmodium falciparum (malaria parasite P. falciparum) | | 4 |
Cyclin-dependent kinase 3 | Homo sapiens (human) | | 0.0118 |
Cyclin-dependent kinase 6 | Homo sapiens (human) | | 0.0395 |
Cyclin-dependent-like kinase 5 | Homo sapiens (human) | | 0.0141 |
Cyclin-dependent kinase 16 | Homo sapiens (human) | | 0.0206 |
Cyclin-dependent kinase 17 | Homo sapiens (human) | | 0.0135 |
Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | | 0.048 |
Protein kinase C epsilon type | Homo sapiens (human) | | 0.0767 |
Dual specificity mitogen-activated protein kinase kinase 1 | Homo sapiens (human) | | 0.2314 |
Angiopoietin-1 receptor | Homo sapiens (human) | | 0.0823 |
Mitogen-activated protein kinase kinase kinase 10 | Homo sapiens (human) | | 0.1952 |
Protein kinase C theta type | Homo sapiens (human) | | 0.1168 |
Activin receptor type-1 | Homo sapiens (human) | | 1.1354 |
Macrophage-stimulating protein receptor | Homo sapiens (human) | | 0.2195 |
Focal adhesion kinase 1 | Homo sapiens (human) | | 0.078 |
Protein kinase C zeta type | Homo sapiens (human) | | 0.1722 |
Protein kinase C delta type | Homo sapiens (human) | | 0.1283 |
Tyrosine-protein kinase BTK | Homo sapiens (human) | | 0.0288 |
Aldehyde oxidase | Homo sapiens (human) | | 0.0023 |
Tyrosine-protein kinase receptor TYRO3 | Homo sapiens (human) | | 0.0177 |
Cyclin-dependent kinase 18 | Homo sapiens (human) | | 0.0587 |
Activated CDC42 kinase 1 | Homo sapiens (human) | | 0.0299 |
Epithelial discoidin domain-containing receptor 1 | Homo sapiens (human) | | 0.9655 |
Tyrosine-protein kinase ITK/TSK | Homo sapiens (human) | | 0.0068 |
Myotonin-protein kinase | Homo sapiens (human) | | 0.1735 |
Mitogen-activated protein kinase kinase kinase 12 | Homo sapiens (human) | | 0.0992 |
Tyrosine-protein kinase Mer | Homo sapiens (human) | | 0.0331 |
Serine/threonine-protein kinase 4 | Homo sapiens (human) | | 0.0013 |
Serine/threonine-protein kinase PAK 1 | Homo sapiens (human) | | 0.0004 |
Dual specificity mitogen-activated protein kinase kinase 5 | Homo sapiens (human) | | 0.0252 |
Mitogen-activated protein kinase 7 | Homo sapiens (human) | | 4.0032 |
Serine/threonine-protein kinase PAK 2 | Homo sapiens (human) | | 0.0021 |
Serine/threonine-protein kinase 3 | Homo sapiens (human) | | 0.0034 |
Mitogen-activated protein kinase kinase kinase 1 | Homo sapiens (human) | | 0.438 |
cGMP-dependent protein kinase 2 | Homo sapiens (human) | | 0.0161 |
Rho-associated protein kinase 1 | Homo sapiens (human) | | 0.0038 |
Non-receptor tyrosine-protein kinase TNK1 | Homo sapiens (human) | | 0.0012 |
Calcium/calmodulin-dependent protein kinase type II subunit beta | Homo sapiens (human) | | 0.0018 |
Calcium/calmodulin-dependent protein kinase type II subunit gamma | Homo sapiens (human) | | 0.0026 |
Calcium/calmodulin-dependent protein kinase type II subunit delta | Homo sapiens (human) | | 0.0024 |
Dual specificity tyrosine-phosphorylation-regulated kinase 1A | Homo sapiens (human) | | 0.0095 |
Bone morphogenetic protein receptor type-2 | Homo sapiens (human) | | 1.94 |
Protein-tyrosine kinase 6 | Homo sapiens (human) | | 0.484 |
cGMP-dependent protein kinase 1 | Homo sapiens (human) | | 0.0027 |
Cyclin-dependent kinase 13 | Homo sapiens (human) | | 0.057 |
Calcium/calmodulin-dependent protein kinase type 1 | Homo sapiens (human) | | 0.0032 |
Inhibitor of nuclear factor kappa-B kinase subunit epsilon | Homo sapiens (human) | | 0.0003 |
Protein-tyrosine kinase 2-beta | Homo sapiens (human) | | 0.0095 |
Maternal embryonic leucine zipper kinase | Homo sapiens (human) | | 0.0006 |
Lysine--tRNA ligase | Homo sapiens (human) | | 0.0049 |
Cyclin-dependent kinase 5 activator 1 | Homo sapiens (human) | | 0.0141 |
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial | Homo sapiens (human) | | 0.0005 |
Serine/threonine-protein kinase D1 | Homo sapiens (human) | | 0.1448 |
Serine/threonine-protein kinase 38 | Homo sapiens (human) | | 0.0037 |
Receptor tyrosine-protein kinase erbB-4 | Homo sapiens (human) | | 0.183 |
Ribosomal protein S6 kinase alpha-2 | Homo sapiens (human) | | 0.0002 |
Ephrin type-A receptor 7 | Homo sapiens (human) | | 0.0477 |
Ribosomal protein S6 kinase alpha-1 | Homo sapiens (human) | | 0.0004 |
Dual specificity testis-specific protein kinase 1 | Homo sapiens (human) | | 0.1995 |
Myosin light chain kinase, smooth muscle | Homo sapiens (human) | | 0.0448 |
TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 | Homo sapiens (human) | | 0.037 |
Mitogen-activated protein kinase 11 | Homo sapiens (human) | | 1 |
Serine/threonine-protein kinase STK11 | Homo sapiens (human) | | 0.0598 |
Rhodopsin kinase GRK1 | Homo sapiens (human) | | 0.068 |
Coiled-coil domain-containing protein 6 | Homo sapiens (human) | | 0.0022 |
NT-3 growth factor receptor | Homo sapiens (human) | | 0.0002 |
Serine/threonine-protein kinase N1 | Homo sapiens (human) | | 0.0025 |
Serine/threonine-protein kinase N2 | Homo sapiens (human) | | 0.0055 |
Mitogen-activated protein kinase 14 | Homo sapiens (human) | | 0.5052 |
Calcium/calmodulin-dependent protein kinase type IV | Homo sapiens (human) | | 0.1475 |
Mitogen-activated protein kinase kinase kinase 11 | Homo sapiens (human) | | 0.016 |
BDNF/NT-3 growth factors receptor | Homo sapiens (human) | | 0.0004 |
MAP kinase-activated protein kinase 3 | Homo sapiens (human) | | 2.775 |
Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform | Homo sapiens (human) | | 0.0017 |
Discoidin domain-containing receptor 2 | Homo sapiens (human) | | 0.0008 |
Thioredoxin reductase 1, cytoplasmic | Homo sapiens (human) | | 0.0432 |
Rho-associated protein kinase 2 | Bos taurus (cattle) | | 0.0417 |
Myosin light chain kinase 3 | Homo sapiens (human) | | 0.1585 |
Serine/threonine-protein kinase SBK1 | Homo sapiens (human) | | 0.1464 |
Mitogen-activated protein kinase kinase kinase 19 | Homo sapiens (human) | | 0.0087 |
Leucine-rich repeat serine/threonine-protein kinase 2 | Homo sapiens (human) | | 0.0077 |
Mitogen-activated protein kinase kinase kinase 21 | Homo sapiens (human) | | 1.1175 |
Serine/threonine-protein kinase MRCK alpha | Homo sapiens (human) | | 0.0032 |
Sigma non-opioid intracellular receptor 1 | Cavia porcellus (domestic guinea pig) | | 0.0067 |
Testis-specific serine/threonine-protein kinase 1 | Mus musculus (house mouse) | | 0.0003 |
Dual specificity tyrosine-phosphorylation-regulated kinase 1A | Rattus norvegicus (Norway rat) | | 0.012 |
Protein kinase C eta type | Rattus norvegicus (Norway rat) | | 0.274 |
Serine/threonine-protein kinase MRCK gamma | Homo sapiens (human) | | 0.0005 |
Calcium/calmodulin-dependent protein kinase type 1B | Homo sapiens (human) | | 0.0044 |
Serine/threonine-protein kinase Nek5 | Homo sapiens (human) | | 0.0864 |
Serine/threonine-protein kinase N3 | Homo sapiens (human) | | 0.0105 |
Serine/threonine-protein kinase ULK3 | Homo sapiens (human) | | 0.0027 |
Kinase suppressor of Ras 2 | Homo sapiens (human) | | 5.4 |
Dual serine/threonine and tyrosine protein kinase | Homo sapiens (human) | | 0.0552 |
Serine/threonine-protein kinase/endoribonuclease IRE2 | Homo sapiens (human) | | 0.0416 |
Serine/threonine-protein kinase MARK2 | Homo sapiens (human) | | 0.0001 |
Serine/threonine-protein kinase TAO1 | Homo sapiens (human) | | 0.0008 |
Serine/threonine-protein kinase Nek8 | Homo sapiens (human) | | 0.0263 |
Serine/threonine-protein kinase tousled-like 2 | Homo sapiens (human) | | 0.0035 |
Serine/threonine-protein kinase 32C | Homo sapiens (human) | | 0.232 |
Serine/threonine-protein kinase pim-3 | Homo sapiens (human) | | 0.0001 |
Myosin light chain kinase family member 4 | Homo sapiens (human) | | 0.0537 |
Homeodomain-interacting protein kinase 1 | Homo sapiens (human) | | 2.639 |
Calcium/calmodulin-dependent protein kinase type 1D | Homo sapiens (human) | | 0.0003 |
Mitogen-activated protein kinase kinase kinase kinase 3 | Homo sapiens (human) | | 0.0001 |
Kinase suppressor of Ras 1 | Homo sapiens (human) | | 6.265 |
Cyclin-dependent kinase-like 3 | Homo sapiens (human) | | 1.1 |
MAP kinase-activated protein kinase 5 | Homo sapiens (human) | | 0.212 |
Serine/threonine-protein kinase BRSK2 | Homo sapiens (human) | | 0.0028 |
Serine/threonine-protein kinase NIM1 | Homo sapiens (human) | | 0.1102 |
Serine/threonine-protein kinase ULK2 | Homo sapiens (human) | | 0.0032 |
Misshapen-like kinase 1 | Homo sapiens (human) | | 0.0004 |
Serine/threonine-protein kinase DCLK2 | Homo sapiens (human) | | 0.089 |
Calcium/calmodulin-dependent protein kinase kinase 1 | Homo sapiens (human) | | 0.0359 |
Casein kinase I isoform alpha-like | Homo sapiens (human) | | 1.84 |
Cyclin-Y | Homo sapiens (human) | | 0.0518 |
Homeodomain-interacting protein kinase 4 | Homo sapiens (human) | | 0.226 |
Myosin-IIIa | Homo sapiens (human) | | 0.0425 |
Serine/threonine-protein kinase Nek11 | Homo sapiens (human) | | 0.521 |
Protein odd-skipped-related 1 | Homo sapiens (human) | | 0.0402 |
Mitogen-activated protein kinase 15 | Homo sapiens (human) | | 0.0081 |
Serine/threonine-protein kinase Nek9 | Homo sapiens (human) | | 0.101 |
Serine/threonine-protein kinase BRSK1 | Homo sapiens (human) | | 0.0007 |
Serine/threonine-protein kinase haspin | Homo sapiens (human) | | 0.0422 |
Rhodopsin kinase GRK7 | Homo sapiens (human) | | 0.0053 |
G2/mitotic-specific cyclin-B3 | Homo sapiens (human) | | 0.0107 |
Myosin-IIIb | Homo sapiens (human) | | 0.0058 |
Dual specificity tyrosine-phosphorylation-regulated kinase 2 | Homo sapiens (human) | | 0.18 |
Phosphorylase b kinase regulatory subunit beta | Homo sapiens (human) | | 0.0005 |
Serine/threonine-protein kinase Sgk3 | Homo sapiens (human) | | 0.073 |
Aurora kinase B | Homo sapiens (human) | | 0.007 |
Lymphokine-activated killer T-cell-originated protein kinase | Homo sapiens (human) | | 0.0691 |
MAP/microtubule affinity-regulating kinase 4 | Homo sapiens (human) | | 0.0001 |
Calcium/calmodulin-dependent protein kinase type 1G | Homo sapiens (human) | | 0.0047 |
Testis-specific serine/threonine-protein kinase 2 | Homo sapiens (human) | | 0.0038 |
Testis-specific serine/threonine-protein kinase 3 | Homo sapiens (human) | | 0.0051 |
Serine/threonine-protein kinase Nek1 | Homo sapiens (human) | | 0.0122 |
PAS domain-containing serine/threonine-protein kinase | Homo sapiens (human) | | 0.0107 |
Calcium/calmodulin-dependent protein kinase kinase 2 | Homo sapiens (human) | | 0.0246 |
SRSF protein kinase 1 | Homo sapiens (human) | | 0.0337 |
Mitogen-activated protein kinase kinase kinase 14 | Homo sapiens (human) | | 2.3 |
Mitogen-activated protein kinase kinase kinase 5 | Homo sapiens (human) | | 0.215 |
Mitogen-activated protein kinase kinase kinase 3 | Homo sapiens (human) | | 0.0092 |
MAP kinase-interacting serine/threonine-protein kinase 1 | Homo sapiens (human) | | 0.0531 |
Testis-specific serine/threonine-protein kinase 6 | Homo sapiens (human) | | 0.1525 |
Serine/threonine-protein kinase 33 | Homo sapiens (human) | | 0.0374 |
Serine/threonine-protein kinase D2 | Homo sapiens (human) | | 0.0014 |
NUAK family SNF1-like kinase 2 | Homo sapiens (human) | | 0.0018 |
Serine/threonine-protein kinase SIK2 | Homo sapiens (human) | | 0.3669 |
Myosin light chain kinase 2, skeletal/cardiac muscle | Homo sapiens (human) | | 0.0147 |
STE20-like serine/threonine-protein kinase | Homo sapiens (human) | | 0.0142 |
Serine/threonine-protein kinase TAO3 | Homo sapiens (human) | | 0.0017 |
Homeodomain-interacting protein kinase 2 | Homo sapiens (human) | | 0.3655 |
Tyrosine-protein kinase Srms | Homo sapiens (human) | | 6.5 |
Homeodomain-interacting protein kinase 3 | Homo sapiens (human) | | 0.456 |
Serine/threonine-protein kinase PLK3 | Homo sapiens (human) | | 0.203 |
Inactive tyrosine-protein kinase PEAK1 | Homo sapiens (human) | | 0.0025 |
Dual specificity protein kinase CLK4 | Homo sapiens (human) | | 0.0723 |
MAP kinase-interacting serine/threonine-protein kinase 2 | Homo sapiens (human) | | 0.0221 |
Serine/threonine-protein kinase Sgk2 | Homo sapiens (human) | | 0.0159 |
Casein kinase I isoform gamma-1 | Homo sapiens (human) | | 5.3367 |
NADPH oxidase 4 | Homo sapiens (human) | | 0.0708 |
Serine/threonine-protein kinase PAK 6 | Homo sapiens (human) | | 0.0327 |
SNF-related serine/threonine-protein kinase | Homo sapiens (human) | | 0.0059 |
Serine/threonine-protein kinase LATS2 | Homo sapiens (human) | | 0.0062 |
Interleukin-1 receptor-associated kinase 4 | Homo sapiens (human) | | 0.0122 |
Serine/threonine-protein kinase 32B | Homo sapiens (human) | | 0.0375 |
Cyclin-dependent kinase 12 | Homo sapiens (human) | | 0.053 |
Serine/threonine-protein kinase PLK2 | Homo sapiens (human) | | 0.546 |
Serine/threonine-protein kinase MARK1 | Homo sapiens (human) | | 0.0003 |
Serine/threonine-protein kinase pim-2 | Homo sapiens (human) | | 0.0813 |
Serine/threonine-protein kinase PAK 5 | Homo sapiens (human) | | 0.0039 |
Serine/threonine-protein kinase 26 | Homo sapiens (human) | | 0.0124 |
Serine/threonine-protein kinase NLK | Homo sapiens (human) | | 0.0666 |
Ribosomal protein S6 kinase beta-2 | Homo sapiens (human) | | 0.0015 |
Protein DBF4 homolog A | Homo sapiens (human) | | 0.0549 |
Serine/threonine-protein kinase 17A | Homo sapiens (human) | | 0.0386 |
STE20/SPS1-related proline-alanine-rich protein kinase | Homo sapiens (human) | | 0.0158 |
Ephrin type-A receptor 6 | Homo sapiens (human) | | 0.0161 |
Serine/threonine-protein kinase TBK1 | Homo sapiens (human) | | 0.003 |
Death-associated protein kinase 2 | Homo sapiens (human) | | 0.0064 |
Ribosomal protein S6 kinase alpha-6 | Homo sapiens (human) | | 0.0001 |
TRAF2 and NCK-interacting protein kinase | Homo sapiens (human) | | 0.0103 |
Serine/threonine-protein kinase tousled-like 1 | Homo sapiens (human) | | 0.0295 |
Serine/threonine-protein kinase TAO2 | Homo sapiens (human) | | 0.0076 |
ALK tyrosine kinase receptor | Homo sapiens (human) | | 0.0044 |
SRSF protein kinase 3 | Homo sapiens (human) | | 1.77 |
Serine/threonine-protein kinase ICK | Homo sapiens (human) | | 0.0443 |
Aurora kinase C | Homo sapiens (human) | | 0.0022 |
Calcium/calmodulin-dependent protein kinase type II subunit alpha | Homo sapiens (human) | | 0.0024 |
Protein kinase C theta type | Rattus norvegicus (Norway rat) | | 0.274 |
RAC-gamma serine/threonine-protein kinase | Homo sapiens (human) | | 0.3701 |
Serine/threonine-protein kinase 38-like | Homo sapiens (human) | | 0.0012 |
Serine/threonine-protein kinase SIK3 | Homo sapiens (human) | | 0.1541 |
Mitogen-activated protein kinase kinase kinase 2 | Homo sapiens (human) | | 0.0335 |
Serine/threonine-protein kinase WNK2 | Homo sapiens (human) | | 1.455 |
Dual specificity tyrosine-phosphorylation-regulated kinase 1B | Homo sapiens (human) | | 0.0017 |
5'-AMP-activated protein kinase subunit beta-1 | Homo sapiens (human) | | 1.1354 |
Mitogen-activated protein kinase kinase kinase kinase 5 | Homo sapiens (human) | | 0.0002 |
Serine/threonine-protein kinase MRCK beta | Homo sapiens (human) | | 0.0027 |
Serine/threonine-protein kinase 24 | Homo sapiens (human) | | 0.0065 |
Casein kinase I isoform gamma-3 | Homo sapiens (human) | | 2.675 |
Chain A, Ribosomal protein S6 kinase alpha-1 | Homo sapiens (human) | | 0.0003 |
Chain X, Tyrosine-protein kinase Lyn | Homo sapiens (human) | | 0.0013 |
Authors | Studies |
Ciceri, P; Davis, MI; Herrgard, S; Hocker, M; Hunt, JP; Pallares, G; Treiber, DK; Wodicka, LM; Zarrinkar, PP | 1 |
Dewhurst, S; Gelbard, HA; Goodfellow, VS; Loweth, CJ; Marker, DF; Nguyen, T; Polesskaya, O; Pollack, S; Ravula, SB; Sheppard, D; Todd, DE; Wiemann, T; Xu, Y | 1 |
Abdel-Aziz, AK; Abouzid, KAM; Dokla, EME; McPhillie, MJ; Milik, SN; Minucci, S | 1 |
Zhang, GS | 1 |
Kiyoi, H | 2 |
Berdel, WE; Müller-Tidow, C; Serve, H; Tickenbrock, L | 1 |
Brown, P; Cohen, P; Deangelo, D; Estey, E; Galinsky, I; Giles, F; Kantarjian, H; Karp, JE; Levis, M; Pham, R; Roesel, J; Small, D; Smith, BD; Stine, A; Stone, R; Wang, Y | 1 |
Austin, SJ; Burnett, AK; Gilkes, AF; Knapper, S; Mills, KI; Walsh, V | 1 |
Ehninger, G; Illmer, T | 1 |
Gary Gilliland, D; Tam, WF | 1 |
Tallman, M | 1 |
Gore, SD | 1 |
Karp, J | 1 |
Armstrong, RC; Belli, B; Bhagwat, SS; Brigham, D; Chao, Q; Cramer, MD; Gardner, MF; Gunawardane, RN; James, J; Karaman, MW; Levis, M; Pallares, G; Patel, HK; Pratz, KW; Sprankle, KG; Zarrinkar, PP | 1 |
Burnett, A; Lo-Coco, F; Löwenberg, B; Sanz, M | 1 |
Levis, M; Murphy, KM; Pratz, KW; Rajkhowa, T; Sato, T; Stine, A | 1 |
Ashman, LK; Griffith, R; Mashkani, B | 1 |
Burnett, A; Galkin, S; Knapper, S; Levis, M; Sato, T; Small, D; Smith, BD; White, P; Yang, X | 1 |
Chabner, BA; Fathi, AT | 1 |
Freeman, C; Giles, F; Swords, R | 1 |
Bharate, SB; Sawant, SD; Singh, PP; Vishwakarma, RA | 1 |
Bai, Y; Bennett, K; Colinge, J; Eschrich, S; Fang, B; Grebien, F; Haura, EB; Kim, JY; Koomen, J; Li, J; Okamoto, I; Qian, X; Rawal, B; Rix, U; Schell, M; Song, L; Stukalov, A; Superti-Furga, G; Winter, G; Yoshida, T; Zhang, G | 1 |
Courts, C; Gallala, H; Janzen, V; Kraus, D; Nowak, M; Perner, S; Probstmeier, R; Veit, N; Winter, J | 1 |
Li, JS; Wang, XW; Wang, YW; Zhang, HY | 1 |
Asami, Y; Crump, A; Ōmura, S | 1 |
Antar, AI; Bazarbachi, A; Jabbour, E; Mohty, M; Otrock, ZK | 1 |
Albors Ferreiro, M; Alonso Vence, N; Antelo Rodríguez, B; Bao Pérez, L; Bello López, JL; Cerchione, C; Cid López, M; Díaz Arias, JÁ; Ferreiro Ferro, R; González Pérez, MS; Martinelli, G; Mosquera Orgueira, A; Mosquera Torre, A; Peleteiro Raíndo, A; Pérez Encinas, MM | 1 |
Article | Year |
[Possibility of targeting FLT3 kinase for the treatment of leukemia].[Rinsho ketsueki] The Japanese journal of clinical hematology, 2005, Volume: 46, Issue:3
Topics: Animals; Antibodies, Monoclonal; Benzoquinones; Carbazoles; Drug Design; Enzyme Inhibitors; fms-Like Tyrosine Kinase 3; Furans; Humans; Indoles; Lactams, Macrocyclic; Leukemia; Mutation; Piperazines; Pyrroles; Quinazolines; Quinones; Rifabutin; Staurosporine; Sunitinib | 2005 |
Emerging Flt3 kinase inhibitors in the treatment of leukaemia.Expert opinion on emerging drugs, 2006, Volume: 11, Issue:1
Topics: Animals; Antineoplastic Agents; Carbazoles; Clinical Trials as Topic; Drug Evaluation, Preclinical; Drug Therapy, Combination; fms-Like Tyrosine Kinase 3; Furans; Humans; Indoles; Leukemia, Myeloid, Acute; Mutation; Protein Kinase Inhibitors; Pyrroles; Signal Transduction; Staurosporine | 2006 |
[Novel molecularly target therapies for leukemia].Nihon rinsho. Japanese journal of clinical medicine, 2007, Jan-28, Volume: 65 Suppl 1Topics: Antineoplastic Agents; Carbazoles; Farnesyltranstransferase; fms-Like Tyrosine Kinase 3; Furans; Humans; Indoles; Leukemia; Piperazines; Quinazolines; Staurosporine | 2007 |
FLT3 kinase inhibitors in the management of acute myeloid leukemia.Clinical lymphoma & myeloma, 2007, Volume: 8 Suppl 1Topics: Benzenesulfonates; Carbazoles; Clinical Trials as Topic; fms-Like Tyrosine Kinase 3; Furans; Humans; Indoles; Leukemia, Myeloid, Acute; Niacinamide; Phenylurea Compounds; Piperazines; Protein Kinase Inhibitors; Pyridines; Pyrroles; Quinazolines; Sorafenib; Staurosporine; Sunitinib | 2007 |
Can FLT3 inhibitors overcome resistance in AML?Best practice & research. Clinical haematology, 2008, Volume: 21, Issue:1
Topics: Antineoplastic Agents; Carbazoles; Clinical Trials as Topic; Drug Design; Drug Resistance, Neoplasm; fms-Like Tyrosine Kinase 3; Furans; Humans; Indoles; Leukemia, Myeloid, Acute; Mutation; Piperazines; Quinazolines; Staurosporine | 2008 |
FLT3 inhibition as a targeted therapy for acute myeloid leukemia.Current opinion in oncology, 2009, Volume: 21, Issue:6
Topics: Acute Disease; Animals; Carbazoles; Drug Evaluation, Preclinical; fms-Like Tyrosine Kinase 3; Furans; Humans; Leukemia, Myeloid; Molecular Structure; Mutation; Staurosporine | 2009 |
Targeting the FMS-like tyrosine kinase 3 in acute myeloid leukemia.Leukemia, 2012, Volume: 26, Issue:10
Topics: Benzenesulfonates; Benzothiazoles; Carbazoles; CCAAT-Enhancer-Binding Protein-alpha; fms-Like Tyrosine Kinase 3; Furans; Humans; Leukemia, Myeloid, Acute; Mutation; Niacinamide; Phenylurea Compounds; Prognosis; Pyridines; Sorafenib; Staurosporine | 2012 |
Kinase inhibitors of marine origin.Chemical reviews, 2013, Aug-14, Volume: 113, Issue:8
Topics: Adenosine Triphosphate; Animals; Antineoplastic Agents; Aquatic Organisms; Aza Compounds; Carbazoles; Chemistry, Pharmaceutical; Depsipeptides; Furans; Humans; Indoles; Naphthyridines; Peptides, Cyclic; Phosphoinositide-3 Kinase Inhibitors; Phosphotransferases (Alcohol Group Acceptor); Protein Kinase Inhibitors; Pyrimidines; Staurosporine; Terpenes | 2013 |
Staurosporine: new lease of life for parent compound of today's novel and highly successful anti-cancer drugs.The Journal of antibiotics, 2018, Volume: 71, Issue:8
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Bacteria; Bacterial Infections; Carbazoles; Drug Discovery; Furans; Humans; Imatinib Mesylate; Neoplasms; Protein Kinase Inhibitors; Staurosporine | 2018 |
FLT3 inhibitors in acute myeloid leukemia: ten frequently asked questions.Leukemia, 2020, Volume: 34, Issue:3
Topics: Aniline Compounds; Antineoplastic Agents; Benzimidazoles; Benzothiazoles; Carbazoles; DNA Methylation; Enzyme Inhibitors; fms-Like Tyrosine Kinase 3; Furans; Humans; Leukemia, Myeloid, Acute; Mutation; Neoplasm Recurrence, Local; Phenylurea Compounds; Piperidines; Prognosis; Pyrazines; Randomized Controlled Trials as Topic; Sorafenib; Staurosporine; Treatment Outcome | 2020 |
FLT3 inhibitors in the treatment of acute myeloid leukemia: current status and future perspectives.Minerva medica, 2020, Volume: 111, Issue:5
Topics: Aniline Compounds; Antineoplastic Agents; Benzimidazoles; Benzothiazoles; Carbazoles; Drug Resistance, Multiple; Drug Resistance, Neoplasm; fms-Like Tyrosine Kinase 3; Forecasting; Furans; Hematopoietic Stem Cell Transplantation; Humans; Imidazoles; Leukemia, Myeloid, Acute; Maintenance Chemotherapy; Mutation; Phenylurea Compounds; Piperidines; Point Mutation; Protein Kinase Inhibitors; Pyrazines; Pyridazines; Recurrence; Sorafenib; Staurosporine | 2020 |
Article | Year |
Comprehensive analysis of kinase inhibitor selectivity.Nature biotechnology, 2011, Oct-30, Volume: 29, Issue:11
Topics: Catalysis; Drug Design; Enzyme Stability; High-Throughput Screening Assays; Humans; Protein Binding; Protein Kinase Inhibitors; Protein Kinases; Proteomics; Signal Transduction; Substrate Specificity | 2011 |
Discovery, synthesis, and characterization of an orally bioavailable, brain penetrant inhibitor of mixed lineage kinase 3.Journal of medicinal chemistry, 2013, Oct-24, Volume: 56, Issue:20
Topics: Administration, Oral; Animals; Area Under Curve; Biological Availability; Blood-Brain Barrier; Brain; Carbazoles; Cells, Cultured; Cognition Disorders; Drug Discovery; HIV Infections; Humans; JNK Mitogen-Activated Protein Kinases; Male; MAP Kinase Kinase Kinases; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase Kinase Kinase 11; Models, Chemical; Molecular Structure; Monocytes; Phosphorylation; Protein Kinase Inhibitors; Pyridines; Pyrroles; tat Gene Products, Human Immunodeficiency Virus; Tumor Necrosis Factor-alpha | 2013 |
Discovery of a benzimidazole-based dual FLT3/TrKA inhibitor targeting acute myeloid leukemia.Bioorganic & medicinal chemistry, 2022, 02-15, Volume: 56Topics: Antineoplastic Agents; Apoptosis; Benzimidazoles; Cell Line; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Discovery; Drug Screening Assays, Antitumor; fms-Like Tyrosine Kinase 3; Humans; Models, Molecular; Molecular Structure; Protein Kinase Inhibitors; Receptor, trkA; Structure-Activity Relationship | 2022 |
[New targets for molecular therapy of acute leukemia: a "single-hit" or "multiple-hit" strategy against signaling pathway].Zhonghua yi xue za zhi, 2005, Feb-23, Volume: 85, Issue:7
Topics: Acute Disease; Antineoplastic Agents; Carbazoles; Furans; Humans; Indoles; Leukemia; Leukemia, Myeloid, Acute; Mutation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein-Tyrosine Kinases; Quinolones; ras Proteins; Staurosporine | 2005 |
Plasma inhibitory activity (PIA): a pharmacodynamic assay reveals insights into the basis for cytotoxic response to FLT3 inhibitors.Blood, 2006, Nov-15, Volume: 108, Issue:10
Topics: Antineoplastic Agents; Carbazoles; Case-Control Studies; Cell Line; Cell Survival; Cells, Cultured; Drug Screening Assays, Antitumor; Enzyme Inhibitors; fms-Like Tyrosine Kinase 3; Furans; Humans; Indoles; Inhibitory Concentration 50; Leukemia; Pharmacokinetics; Plasma; Staurosporine | 2006 |
The effects of lestaurtinib (CEP701) and PKC412 on primary AML blasts: the induction of cytotoxicity varies with dependence on FLT3 signaling in both FLT3-mutated and wild-type cases.Blood, 2006, Nov-15, Volume: 108, Issue:10
Topics: Acute Disease; Adolescent; Adult; Aged; Apoptosis; Blast Crisis; Carbazoles; Drug Screening Assays, Antitumor; Female; fms-Like Tyrosine Kinase 3; Furans; Humans; Indoles; Leukemia, Myeloid; Male; Middle Aged; Mutation; Protein Kinase C; Protein-Tyrosine Kinases; Signal Transduction; Staurosporine; Tumor Cells, Cultured | 2006 |
Existing and emerging therapeutic options for the treatment of acute myeloid leukemia.Clinical advances in hematology & oncology : H&O, 2008, Volume: 6, Issue:11
Topics: Adenine; Adenine Nucleotides; Aminoglycosides; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Arabinonucleosides; Carbazoles; Clofarabine; Cytarabine; Dasatinib; Daunorubicin; fms-Like Tyrosine Kinase 3; Furans; Gemtuzumab; Humans; Leukemia, Myeloid, Acute; Naphthalimides; Organophosphonates; Prognosis; Protein Kinase Inhibitors; Pyrimidines; Sesquiterpenes; Staurosporine; Stem Cell Transplantation; Thiazoles; Tretinoin | 2008 |
New agents for the treatment of AML recent study findings.Clinical advances in hematology & oncology : H&O, 2008, Volume: 6, Issue:11
Topics: Adenine Nucleotides; Antineoplastic Agents; Arabinonucleosides; Azacitidine; Carbazoles; Clofarabine; Decitabine; Enzyme Inhibitors; Furans; Humans; Hydrazines; Immunotherapy; Lenalidomide; Leukemia, Myeloid, Acute; Quinolones; Staurosporine; Sulfonamides; Thalidomide | 2008 |
Future research directions for the treatment of AML.Clinical advances in hematology & oncology : H&O, 2008, Volume: 6, Issue:11
Topics: Antineoplastic Agents; Azacitidine; Biomedical Research; Carbazoles; Carboplatin; Cytarabine; Daunorubicin; Decitabine; Enzyme Inhibitors; Etoposide; Flavonoids; Furans; Humans; Leukemia, Myeloid, Acute; Mitoxantrone; Piperidines; Quinolones; Staurosporine; Topotecan; Tretinoin | 2008 |
AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML).Blood, 2009, Oct-01, Volume: 114, Issue:14
Topics: Animals; Benzenesulfonates; Benzothiazoles; Bone Marrow; Carbazoles; Cell Line, Tumor; Cell Proliferation; Female; fms-Like Tyrosine Kinase 3; Furans; Humans; Leukemia, Myeloid, Acute; Mice; Mice, Nude; Mice, SCID; Niacinamide; Phenylurea Compounds; Phosphorylation; Piperazines; Prognosis; Protein Interaction Mapping; Protein Kinase C; Protein Kinase Inhibitors; Pyridines; Quinazolines; Sorafenib; Staurosporine; Xenograft Model Antitumor Assays | 2009 |
FLT3-mutant allelic burden and clinical status are predictive of response to FLT3 inhibitors in AML.Blood, 2010, Feb-18, Volume: 115, Issue:7
Topics: Alleles; Antineoplastic Agents; Benzenesulfonates; Benzothiazoles; Carbazoles; Cell Death; Cell Line, Tumor; Drug Resistance, Neoplasm; fms-Like Tyrosine Kinase 3; Furans; Humans; Indazoles; Indoles; Leukemia, Myeloid, Acute; Mutation; Niacinamide; Phenylurea Compounds; Phosphorylation; Piperazines; Pyridines; Pyrroles; Sorafenib; Staurosporine; Sunitinib | 2010 |
Colony stimulating factor-1 receptor as a target for small molecule inhibitors.Bioorganic & medicinal chemistry, 2010, Mar-01, Volume: 18, Issue:5
Topics: Benzamides; Binding Sites; Carbazoles; Computer Simulation; Dasatinib; Drug Design; Furans; Humans; Hydrogen Bonding; Imatinib Mesylate; Indoles; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Receptor, Macrophage Colony-Stimulating Factor; Staurosporine; Sunitinib; Thiazoles | 2010 |
FLT3 ligand impedes the efficacy of FLT3 inhibitors in vitro and in vivo.Blood, 2011, Mar-24, Volume: 117, Issue:12
Topics: Antineoplastic Agents; Benzenesulfonates; Carbazoles; Cells, Cultured; Drug Antagonism; fms-Like Tyrosine Kinase 3; Furans; Humans; Indazoles; Inhibitory Concentration 50; Leukemia, Myeloid, Acute; Membrane Proteins; Multicenter Studies as Topic; Niacinamide; Phenylurea Compounds; Piperazines; Protein Kinase Inhibitors; Pyridines; Randomized Controlled Trials as Topic; Sorafenib; Staurosporine; Treatment Outcome | 2011 |
FLT3 inhibition as therapy in acute myeloid leukemia: a record of trials and tribulations.The oncologist, 2011, Volume: 16, Issue:8
Topics: Antineoplastic Agents; Benzothiazoles; Carbazoles; Clinical Trials as Topic; Cytokines; fms-Like Tyrosine Kinase 3; Furans; Humans; Indoles; Leukemia, Myeloid, Acute; Phenylurea Compounds; Pyrroles; Staurosporine; Sunitinib; Tandem Repeat Sequences | 2011 |
Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanisms.Molecular systems biology, 2013, Nov-05, Volume: 9Topics: Antineoplastic Agents; Carbazoles; Cell Line, Tumor; Cell Survival; Drug Resistance, Neoplasm; Drug Synergism; ErbB Receptors; Erlotinib Hydrochloride; Furans; Gene Expression Regulation, Neoplastic; Humans; Mutation; Neoplasm Proteins; Phosphorylation; Protein Interaction Maps; Protein Kinase Inhibitors; Quinazolines; Staurosporine | 2013 |
Staurosporine analogs promote distinct patterns of process outgrowth and polyploidy in small cell lung carcinoma cells.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2015, Volume: 36, Issue:4
Topics: Carbazoles; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Furans; Humans; Indole Alkaloids; Polyploidy; Signal Transduction; Small Cell Lung Carcinoma; Staurosporine | 2015 |
Integrated Exploitation of the Structural Diversity Space of Chemotherapy Drugs to Selectively Inhibit HER2 T798M Mutant in Lung Cancer.Chemistry & biodiversity, 2017, Volume: 14, Issue:3
Topics: Binding Sites; Carbazoles; Catalytic Domain; Furans; Humans; Kinetics; Ligands; Lung Neoplasms; Molecular Docking Simulation; Mutation; Protein Binding; Protein Kinase Inhibitors; Receptor, ErbB-2; Staurosporine; Thermodynamics | 2017 |